Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$181.58 - $368.0 $422,536 - $856,336
-2,327 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$303.87 - $423.8 $30,690 - $42,803
-101 Reduced 4.16%
2,327 $813,000
Q4 2021

Jan 19, 2022

SELL
$347.28 - $421.83 $587,945 - $714,158
-1,693 Reduced 41.08%
2,428 $924,000
Q3 2021

Oct 05, 2021

BUY
$405.61 - $524.84 $4,056 - $5,248
10 Added 0.24%
4,121 $1.67 Million
Q2 2021

Jul 12, 2021

SELL
$372.84 - $481.5 $329,963 - $426,127
-885 Reduced 17.71%
4,111 $1.95 Million
Q1 2021

Apr 22, 2021

SELL
$361.28 - $504.76 $164,743 - $230,170
-456 Reduced 8.36%
4,996 $1.92 Million
Q4 2020

Jan 25, 2021

BUY
$292.7 - $370.96 $198,157 - $251,139
677 Added 14.18%
5,452 $2.02 Million
Q3 2020

Oct 16, 2020

BUY
$268.51 - $400.74 $360,071 - $537,392
1,341 Added 39.05%
4,775 $1.48 Million
Q2 2020

Jul 08, 2020

SELL
$256.46 - $373.01 $40,520 - $58,935
-158 Reduced 4.4%
3,434 $1.27 Million
Q1 2020

Apr 07, 2020

BUY
$209.2 - $335.53 $279,909 - $448,939
1,338 Added 59.36%
3,592 $981,000
Q3 2019

Nov 06, 2019

SELL
$266.84 - $378.23 $7,204 - $10,212
-27 Reduced 1.18%
2,254 $686,000
Q2 2019

Aug 13, 2019

BUY
$300.59 - $368.15 $14,127 - $17,303
47 Added 2.1%
2,281 $840,000
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $45,773 - $61,578
-168 Reduced 6.99%
2,234 $670,000
Q3 2018

Nov 07, 2018

SELL
$279.04 - $367.06 $114,964 - $151,228
-412 Reduced 14.64%
2,402 $882,000
Q2 2018

Aug 13, 2018

SELL
$228.17 - $292.07 $91,268 - $116,828
-400 Reduced 12.45%
2,814 $786,000
Q1 2018

May 10, 2018

SELL
$209.54 - $253.91 $88,635 - $107,403
-423 Reduced 11.63%
3,214 $760,000
Q4 2017

Feb 07, 2018

BUY
$202.23 - $230.03 $12,133 - $13,801
60 Added 1.68%
3,637 $873,000
Q3 2017

Nov 07, 2017

BUY
$172.3 - $213.93 $616,317 - $765,227
3,577
3,577 $782,000

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Ibm Retirement Fund Portfolio

Follow Ibm Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.